Phreesia remains resilient, maintaining guidance and showing strong financial performance. Find out why I remain bullish on ...

Phreesia (NYSE:PHR – Free Report) had its price objective upped by Canaccord Genuity Group from $34.00 to $35.00 in a report issued on Thursday,Benzinga reports. They currently have a buy rating on ...

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, ...

Healthcare technology company Phreesia (NYSE:PHR) in Q4 CY2024, with sales up 15.4% year on year to $109.7 million. The ...

Q4 2025 Earnings Call Transcript March 12, 2025 Phreesia, Inc. beats earnings expectations. Reported EPS is $-0.11, ...

Phreesia (NYSE:PHR – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities research analysts at Needham & Company LLC in a research report issued on Thursday,Benzinga reports. They ...

In a report released today, Scott Schoenhaus from KeyBanc maintained a Buy rating on Phreesia (PHR – Research Report), with a price target of ...

Truist Financial analyst Jailendra Singh maintained a Buy rating on Phreesia (PHR – Research Report) today. The company’s shares closed ...

Phreesia Inc (PHR) reports a 15% increase in revenue and maintains positive cash flow, despite facing macroeconomic ...

Kayla DeMong fought tears as she described the dire conditions on the front lines, pleading for more help from the province ...